Beryl Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Beryl Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-220,189	Closed	-$4.18M	–	40
2019 Q1	$4.18M	Buy	+220,189	New	+$3.57M	0.77%	17

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Beryl Capital Management's OSIR Position: Q2 2019 in Review

Beryl Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 220,189 shares — an estimated $4.18M sold.

Beryl Capital Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $4.18M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Beryl Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Beryl Capital Management sold 220,189 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $4.18M.
Beryl Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
Beryl Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $4.18M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Beryl Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.